Pfizer will be cutting 6,000 jobs

Pfizer Global Manufacturing Announces Plans To Reconfigure Its Global Plant Network

- - -

Eight Sites Targeted for Exit; Reductions Recommended At Six Plants; Operations to Expand at Others

NEW YORK, N.Y., May 18 - Pfizer Global Manufacturing announced today plans to reconfigure its worldwide plant network to create a fully aligned manufacturing and supply organization from the combined networks of Pfizer and Wyeth... These changes will result in a global reduction of approximately 6,000 jobs over the next several years.



Recommended Site Exits:

• Caguas, Puerto Rico (solid-dose)
• Carolina, Puerto Rico (aseptic)
• Dublin, Ireland (aseptic)
• Loughbeg, Ireland (solid-dose)
• Shanbally, Ireland (biotechnology)
• Rouses Point, N.Y. (solid-dose)
• Richmond, Virginia (consumer healthcare manufacturing targeted for exit; R&D operations to remain in Richmond)
• Pearl River, N.Y. (proposed exit of biotechnology and consumer healthcare manufacturing; vaccines and biotherapeutics vaccines R&D will remain active at this site)

Recommended Plant Reductions:

• Guayama, Puerto Rico (phase-out of pharmaceutical solid dose operations planned; volume increases in consumer healthcare)
• Newbridge, Ireland (solid-dose)
• Andover, Mass., U.S. (biotechnology)
• Sanford, N.C., U.S. (biotechnology)
• Havant, UK (biotechnology)
• Illertissen, Germany (solid-dose)

You can read the full press release here (PDF).